Study to Assess the Safety, Tolerability, and Pharmacokinetics/Pharmacodynamics of GW003 in Patients With Breast Cancer
Clinical trial NCT02725606 · UNKNOWN
Trial details
- NCT number
- NCT02725606
- Sponsor
- Jiangsu T-Mab Biopharma Co.,Ltd
- Status
- UNKNOWN
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2016-03-01
- Primary completion
- 2017-09-01
- Enrollment
- 30
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.